Neion Bio Secures $23 Million in Latest Series A Funding Round

Neion Bio secured $23 million in its latest Series A, adding another data point to the Legal, Regulatory & Compliance funding market.

Neion Bio Raises $23 million in Funding

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Neion Bio operates in Legal, Regulatory & Compliance. Neion Bio's Series A round shows investors are still backing legaltech platforms with real scale narratives. At $23M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Advance Biologics Manufacturing Platform and Expand Pipeline.

Looking Ahead

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline

Source reference: original announcement/article.